icam 1 fc 720 ic 050 chimeras (R&D Systems)
Structured Review
Icam 1 Fc 720 Ic 050 Chimeras, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 70 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd54/Recombinant+Human+ICAM-1%2FCD54+Fc+Chimera+Protein%2C+CF/pmc04366606-97-4-10
Average 94 stars, based on 70 article reviews
Images
Related Articles
Recombinant:Article Title: Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models. Article Snippet: .. When indicated, DOT cells were activated with different concentrations of coated recombinant Article Title: Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models Article Snippet: .. When indicated, DOT cells were activated with different concentrations of coated recombinant Article Title: Identifying a potential role of immune cells in gadolinium deposition within the brain Article Snippet: .. In brief, wells of 12-well (5.2 mm) slides (Epredia speciality printed microscope slide, Ref XEXER202W) were coated directly with either 10 μg/mL Article Title: Highly adaptable deep-learning platform for automated detection and analysis of vesicle exocytosis Article Snippet: Cells were patch-clamped in whole cell recording modus using an EPC-9 patch-clamp amplifier controlled by the PULSE software (Heka Elektronik, Lambrecht, Germany). .. To induce immunological synapse formation followed by lytic granule exocytosis μ-Slide 15 Well 3D glass bottom slides (Ibidi, Biovalley Cat# 81507) were coated with poly-D-lysine (1:10, Sigma-Aldrich Cat# P6407), human monoclonal anti-CD3 antibody (TR66) (5 μg/mL or 10 μg/mL, Enzo Life Sciences Cat# ALX-804-822) and Article Title: Supporting information Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye Article Snippet: .. Labeled cells were incubated in 70 μL of assay medium in each well of a 96- well plate at 500,000 cells per well with 70 μL of SAR 1118 or the positive control in assay medium at 37 °C for 30 min. A 100 μL aliquot of this fluorescence-labeled Jurkat cell suspension was allowed to settle in the presence of SAR 1118 or the positive control in wells of a 96-well plate coated with recombinant other:Article Title: Stenocytosis : a mechanism for supramolecular attack particle transfer at the CTL lytic synapse Article Snippet: The 3D live imaging was performed on human CTL loaded overnight with Wheat Germ Agglutinin Alexa Fluor 488 (50 ng/mL, Molecular Probes, Invitrogen), and loaded 30 minutes with Vybrant DiD (1 μM) (Molecular Probes, Invitrogen). Article Title: Stenocytosis : a mechanism for supramolecular attack particle transfer at the CTL lytic synapse Article Snippet: Human CTL were loaded overnight with Wheat Germ Agglutinin Alexa Fluor 488 (1μg/mL) (Molecular Probes, Invitrogen) or WGA Alexa Fluor 647 (0,5μg/mL or 0,1μg/mL) washed and subsequently loaded with Vybrant Dil (Invitrogen) (1μM) and CellMask Green Actin Tracking Stain (5X) (Invitrogen) or SPY620-actin (4X) (Spirochrome AG) for 30 minutes at 37°C and 5% CO 2 in RPMI 5% FCS/HEPES. Article Title: Stenocytosis : a mechanism for supramolecular attack particle transfer at the CTL lytic synapse Article Snippet: Electroporated cells were loaded over night with WGA Alexa Fluor 405 (1μg/mL) or WGA Alexa Fluor 647 (0,1 μg/mL), washed and loaded 30 minutes with CellMask Green Actin Tracking Stain (4X) (Invitrogen). Microscopy:Article Title: Identifying a potential role of immune cells in gadolinium deposition within the brain Article Snippet: .. In brief, wells of 12-well (5.2 mm) slides (Epredia speciality printed microscope slide, Ref XEXER202W) were coated directly with either 10 μg/mL Labeling:Article Title: Supporting information Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye Article Snippet: .. Labeled cells were incubated in 70 μL of assay medium in each well of a 96- well plate at 500,000 cells per well with 70 μL of SAR 1118 or the positive control in assay medium at 37 °C for 30 min. A 100 μL aliquot of this fluorescence-labeled Jurkat cell suspension was allowed to settle in the presence of SAR 1118 or the positive control in wells of a 96-well plate coated with recombinant Incubation:Article Title: Supporting information Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye Article Snippet: .. Labeled cells were incubated in 70 μL of assay medium in each well of a 96- well plate at 500,000 cells per well with 70 μL of SAR 1118 or the positive control in assay medium at 37 °C for 30 min. A 100 μL aliquot of this fluorescence-labeled Jurkat cell suspension was allowed to settle in the presence of SAR 1118 or the positive control in wells of a 96-well plate coated with recombinant Positive Control:Article Title: Supporting information Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye Article Snippet: .. Labeled cells were incubated in 70 μL of assay medium in each well of a 96- well plate at 500,000 cells per well with 70 μL of SAR 1118 or the positive control in assay medium at 37 °C for 30 min. A 100 μL aliquot of this fluorescence-labeled Jurkat cell suspension was allowed to settle in the presence of SAR 1118 or the positive control in wells of a 96-well plate coated with recombinant Fluorescence:Article Title: Supporting information Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye Article Snippet: .. Labeled cells were incubated in 70 μL of assay medium in each well of a 96- well plate at 500,000 cells per well with 70 μL of SAR 1118 or the positive control in assay medium at 37 °C for 30 min. A 100 μL aliquot of this fluorescence-labeled Jurkat cell suspension was allowed to settle in the presence of SAR 1118 or the positive control in wells of a 96-well plate coated with recombinant Suspension:Article Title: Supporting information Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye Article Snippet: .. Labeled cells were incubated in 70 μL of assay medium in each well of a 96- well plate at 500,000 cells per well with 70 μL of SAR 1118 or the positive control in assay medium at 37 °C for 30 min. A 100 μL aliquot of this fluorescence-labeled Jurkat cell suspension was allowed to settle in the presence of SAR 1118 or the positive control in wells of a 96-well plate coated with recombinant |

